Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation

Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage renal disease with a high rate of recurrence after kidney transplantation. Several factors, such as white race, rapid progression, and previous allograft failure due to recurrence, were found to be risks of recurrence. Data are...

Full description

Bibliographic Details

Published in:	Transplantation Vol. 102; no. 3; p. e115
Main Authors:	Alasfar, Sami, Matar, Dany, Montgomery, Robert A, Desai, Niraj, Lonze, Bonnie, Vujjini, Vikas, Estrella, Michelle M, Manllo Dieck, John, Khneizer, Gebran, Sever, Sanja, Reiser, Jochen, Alachkar, Nada
Format:	Journal Article
Language:	English
Published:	United States 01.03.2018
Subjects:	Adolescent Adult Female Glomerulosclerosis, Focal Segmental - etiology Glomerulosclerosis, Focal Segmental - prevention & control Humans Kidney Transplantation - adverse effects Male Middle Aged Plasma Exchange Prospective Studies Recurrence Rituximab - therapeutic use Young Adult
ISSN:	1534-6080, 1534-6080
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!